Join our Keck Graduate Institute (KGI) community as we share behind-the-scenes insights on the innovation and collaboration taking place on campus. On this podcast, we share conversations with students, faculty, staff, alumni, and other guests. Visit our website at kgi.edu and follow us on social media @KeckGrad.
#126 - KGI Student Government
In this episode, we are featuring KGI student government leaders Erik Wehse, Divij Gulati, and Narine Kareptyan. Through the interview, they discuss how they became interested in science and healthcare, their KGI experience, how COVID-19 has impacted their learning, and their career aspirations.
We encourage you to connect with KGI Student Government on Instagram: @kgistudentgov.
#125 - Rob Tenerowicz
As part of KGI's Industry Talk series, this episode features Rob Tenerowicz, Senior VP of Global Supply and Planning at BioMarin.
Rob Tenerowicz joined BioMarin in September 2011 and serves as Senior Vice President, Global Supply and Planning. His responsibilities include supply chain, engineering, program management, and strategic network planning.
Rob has 35 years of biotechnology industry and product development experience, which includes his time working for XOMA, GenVec, Abgenix, Cell Genesys, and Genentech. He has experience managing a broad range of line functions including project management, engineering, manufacturing, supply chain, and logistics. He also has experience overseeing successful government contracting business units.
He holds a BS in Physiology from the University of California at Davis and an MBA in Operations Management from Golden Gate University.
#124 - Neelu Gibson
As part of KGI's Industry Talk Series, our most recent guest was Neelu Gibson. Gibson serves as the Worldwide Vice President, Regulatory Affairs, Medication Management Solutions (MMS), at BD Medical. She is proud to lead a dynamic team of global professionals in creating and executing regulatory strategies and submissions facilitating the availability of the MMS portfolio of products to healthcare professionals and patients worldwide.
Prior to joining BD in February 2020, Neelu spent 20+ years with the Johnson & Johnson Family of Companies (J&J), where she held positions of increasing responsibility in Regulatory Affairs at Advanced Sterilization Products, Biosense Webster, Ethicon Inc., Mentor Worldwide, Sedasys, Sterilmed and J&J Surgical Vision. Neelu has experiences spanning pre-approval regulatory submissions for medical devices and combination products, and managing post-market regulatory requirements.
Neelu holds a BSc. Environmental Science from the U.K. and has obtained her Regulatory Affairs Certification, issued by the Regulatory Affairs Professionals’ Society (RAPS-US).
Neelu is passionate about personal and professional development and continues to share her leadership experiences by volunteering her time with veterans, students, and industry groups. She and is an active member of RAPS and OCRA, and has co-authored two Amazon best-selling non-fiction books related to leadership.
#123 - Ravneesh Sachdev
This KGI Industry Talk features Ravneesh Sachdev, the Vice President and Head of Business Development at Sage Therapeutics, based in Cambridge, MA. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, including Zulresso™, the first FDA-approved drug specifically for postpartum depression. Ravneesh evaluates and transacts on partnerships in order to inorganically grow Sage’s business.
Over the past 15+ years of his business development career, Ravneesh has contributed to, as well as led, the execution of more than 20 partnerships during his tenure at several other companies, namely Pfizer, Onyx Pharmaceuticals (now part of Amgen), UCB Pharma, Acorda Therapeutics, and Bioverativ (now part of Sanofi).
Ravneesh earned his bachelor’s degree in Molecular Neuroscience from Claremont McKenna College, his Master of Business and Science degree from KGI, and his MBA in Healthcare Leadership from Yale University School of Management.
#122 - Lisa Purcell & Alina Baum
As part of KGI's Industry Speaker Series, Trustee Ross Grossman interviewed two Regeneron leaders: Dr. Lisa Purcell, Senior Manager, Clinical Sciences, Immunology and Inflammation, and Dr. Alina Baum, Senior Staff Scientist.
Lisa Purcell joined Regeneron in 2008 and is a Clinical Scientist in Immunology and Inflammation. She received her PhD from McGill University and completed her Postdoctoral Training at Columbia University. Dr. Purcell’s current work focuses on the clinical development of therapies within the immunology and infectious disease therapeutic areas, including those for SARS-CoV-2/COVID-19. She has also developed therapies for pathogens using Regeneron’s novel technologies. Dr. Purcell is the scientific director of Regeneron’s science education efforts, including the Regeneron Science Talent Search, research mentorship efforts, the International and Westchester Science and Engineering Fair, and STEM teacher programs.
Alina Baum is a Senior Staff Scientist at Regeneron Pharmaceuticals where she is leading the COVID-19 spike antibody program currently in clinical trials. She received her PhD in molecular virology from the lab of Adolfo Garcia-Sastre at Mount Sinai School of Medicine and performed postdoctoral studies with Charlie Rice at Rockefeller University. Her academic career focused on studying interactions between RNA viruses and the innate immune system. In her current position at Regeneron, she is leading a virology research group developing novel therapies for viral infections including influenza and hepatitis B, and emerging pathogens such as Ebola and SARS-CoV-2, as well as the development of oncolytic viruses and vaccines for cancer immunotherapy.
#121 - David Robinson
In this event, KGI Dean of Research Larry Grill interviewed David Robinson, Deputy Director, CMC Vaccines Development and Surveillance at the Bill & Melinda Gates Foundation. Dr. Robinson and his team work with internal and external partners to develop and execute CMC strategies and harness advances in science and technology that enable vaccine development to save lives in developing countries.
Dr. Robinson has 25 years of experience in global vaccine and biologics product commercialization, process development, and CMC regulatory strategy and execution. He received his bachelor’s degree in chemical engineering from UC Berkeley, his PhD from MIT, and did his postdoctoral research at the Swiss Federal Institute of Technology (ETH).
Customer ReviewsSee All
Hear about amazing things happening at the institute as well as interesting developments in the health sciences and biotech industries.
This podcast is a fantastic cross representation of our community of both internal and external stakeholders! #innovatorsstarthere